EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Adenine phosphoribosyltransferase (APRT) deficiency: an increasingly recognized disease

Esther Huimin Leow, Indra Ganesan, Siew Le Chong, Celeste Jia Ying Yap, Sing Ming Chao, Fan Wang, Yong Hong Ng

International Urology and Nephrology · 2025

DOI: 10.1007/s11255-025-04420-6 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Urology and Nephrology, 2025. Verfasst von Esther Huimin Leow und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Paediatrics, Nephrology Service, KK Women's and Children's Hospital, 100 Bukit Timah Road, Singapore, 229899, Singapore. Esther.Leow.H.…. Hauptthemen laut MEDLINE: Adenine Phosphoribosyltransferase, Metabolism, Inborn Errors. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 77 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Adenine phosphoribosyltransferase (APRT) deficiency is a rare autosomal recessive disorder which causes high urinary 2,8-dihydroxyadenine (2,8-DHA) excretion, resulting in urolithiasis and crystal nephropathy. It is caused by mutations in the APRT gene. Even though it is an inherited kidney stone disease, the varied clinical presentations, even within a family with the same underlying genetic variants, can lead to delayed diagnosis with some only being recognized in adulthood and even, following a kidney transplant. First presentations include symptoms of reddish-brown diaper stains, urinary tract infections, urolithiasis, acute kidney injury from obstructive uropathy and/or intratubular 2,8-DHA crystallization or kidney failure. Siblings of index cases should be screened for APRT deficiency. An early diagnosis and treatment with xanthine oxidoreductase inhibitors (XORi) can preserve kidney function and/or prevent progressive kidney injury and kidney failure. In this review, we will discuss the pathophysiology, clinical presentations, investigations, and management of APRT deficiency.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adenine PhosphoribosyltransferaseMetabolism, Inborn ErrorsHumansUrolithiasisAdenine

Stichwörter der Autor:innen

2,8-Dihydroadenine crystalsDHA nephropathyUrolithiasis

Substanzen

Adenine Phosphoribosyltransferase2,8-dihydroxyadenineAdenine

Autor:innen und Institutionen

  • Department of Paediatrics, Nephrology Service, KK Women's and Children's Hospital, 100 Bukit Timah Road, Singapore, 229899, Singapore. Esther.Leow.H.M@singhealth.com.sg.
  • Department of Paediatrics, Nephrology Service, KK Women's and Children's Hospital, 100 Bukit Timah Road, Singapore, 229899, Singapore.
  • Nursing Clinical Services, KK Women's and Children's Hospital, Singapore, Singapore.

Zitieren

APA

Leow, E. H., Ganesan, I., Chong, S. L., Yap, C. J. Y., Chao, S. M., Wang, F., & Ng, Y. H. (2025). Adenine phosphoribosyltransferase (APRT) deficiency: an increasingly recognized disease. International Urology and Nephrology. https://doi.org/10.1007/s11255-025-04420-6

Vancouver

Leow EH, Ganesan I, Chong SL, Yap CJY, Chao SM, Wang F, et al. Adenine phosphoribosyltransferase (APRT) deficiency: an increasingly recognized disease. International Urology and Nephrology. 2025. doi:10.1007/s11255-025-04420-6

BibTeX
@article{Leow2025,
  author = {Leow, Esther Huimin and Ganesan, Indra and Chong, Siew Le and Yap, Celeste Jia Ying and Chao, Sing Ming and Wang, Fan and Ng, Yong Hong},
  title = {Adenine phosphoribosyltransferase (APRT) deficiency: an increasingly recognized disease},
  journal = {International Urology and Nephrology},
  year = {2025},
  doi = {10.1007/s11255-025-04420-6}
}
Kostenlos starten →